Intracerebral haemorrhage

Last revised by Tariq Walizai on 20 Jan 2025

Intracerebral haemorrhage (ICH), also known as intraparenchymal cerebral haemorrhage and often synonymously describing haemorrhagic stroke, is a subset of an intracranial haemorrhage as well as of stroke, defined by the acute accumulation of blood within the brain parenchyma.

This article concerns non-traumatic intracerebral haemorrhages; traumatic haemorrhagic cerebral contusions are discussed separately.

By convention, intracerebral haemorrhage refers to macroscopically visible, recent haemorrhages. In contrast, cerebral microhaemorrhages are discussed separately.

An intracerebral haemorrhage presents similarly to an ischaemic stroke and there are no reliable clinical differentiators between the two. There is typically a rapid onset of focal neurological deficit, which varies depending on the specific area of the brain that is involved. Compared to ischaemic stroke, there is more likely to be a decreased conscious state 11. Other common clinical features include 13:

  • headache

  • nausea and vomiting

  • seizure

Intracerebral haemorrhages arise from rupture of a small blood vessel within the brain parenchyma or, less commonly, of a blood vessel adjacent to the parenchyma (e.g. jet haematoma).

Non-traumatic intracerebral haemorrhages were historically aetiologically divided according to whether or not they have an underlying structural lesion or bleeding diathesis.

  1. spontaneous intracerebral haemorrhage presumed due to small vessel disease (formerly primary intracerebral haemorrhage 10)

  2. secondary intracerebral haemorrhage: haemorrhage complicating some underlying structural lesion or bleeding diathesis

Aetiologies more commonly seen in the paediatric or young adult demographic are discussed separately: see stroke in children and young adults.

Non-traumatic intracerebral haemorrhages are classified by location, which vary by aetiologic association 9.

CT is usually the modality first obtained and demonstrates a hyperdense collection of blood, often with surrounding hypodense oedema. A number of complications may be present, such as extension of the haemorrhage into other intracranial compartments, hydrocephalus, herniation, etc.

A number of CT features can predict the likelihood of haemorrhage expansion and are therefore useful in decision-making and prognosis.

  • non-contrast CT

    • haemorrhage size

      • the volume of an intracerebral haemorrhage can be measured using ABC/2 formula or 3D volumetric software

      • haemorrhage size is considered to be the most reliable independent predictor of ICH expansion

      • haematoma expansion is measured as an increased growth >12.5 mL or volume >33% from the initial CT scan

      • haematomas with a volume of more than 30 mL are more prone to expansion

    • haemorrhage shape

      • intracerebral haemorrhage irregularity is thought to be due to multiple leaking vessels feeding the haematoma

      • haemorrhages with irregular shapes are more prone to expansion

    • haemorrhage density

      • the presence of hypodense or isodense regions within the hyperdense intracerebral haemorrhage represents active bleeding and is called swirl sign

      • when the swirl sign is encapsulated it is termed black hole sign

      • the presence of a relatively hypodense area adjacent to a hyperdense area is termed the blend sign

      • heterogeneous haemorrhage with hypodense foci is more prone to expansion

    • intraventricular haemorrhagic extension​

      • intraventricular haemorrhagic extension occurs due to decompression of the haemorrhage into the low resistance ventricular system, thus; haematomas located in the thalamus, caudate nucleus or pons are more prone to intraventricular extension than lobar haematomas

      • a study has shown that lenticular and lobar haematomas with accompanying intraventricular extension displayed a higher proportion of haematoma expansion 5

  • contrast-enhanced CT

    • active contrast extravasation within haematoma predicts future haemorrhage expansion, this can be observed on CT angiography (CTA) as spot sign and pooling of contrast within the haematoma

Findings depend on the size and age of the bleed (see ageing blood on MRI). MRI may also reveal clues to the aetiology, such as those of cerebral small vessel diseases (e.g. hypertensive microangiopathy, cerebral amyloid angiopathy).

Management is time-critical 14,15, with the principles of management including 12:

  • control of blood pressure, aiming for a systolic blood pressure of ~140 mmHg

  • reversal of any anticoagulation or coagulopathy

    • there is a paucity of evidence to support the effectiveness of routine use of haemostatic agents

  • management of raised intracranial pressure

  • neurosurgical haematoma evacuation can be considered on a case-by-case basis

  • management of seizures with antiseizure medications

    • there is a paucity of evidence to support the effectiveness of antiseizure medication prophylaxis for patients without seizures

Additionally, supportive care should be provided, including caring for patients in dedicated inpatient stroke units and attempting to prevent the numerous complications which are encountered by patients with neurological impairment from stroke.

With any intracerebral haemorrhage the following points should be included in a report as they have prognostic implications 3:

  • location

  • size/volume

    • the ABC/2 formula is widely used, but there may be more accurate formulas (e.g. 2.5ABC/6, SH/2) and analyses available, some of which, however, may require the addition of specific software to the standard PACS tools

  • shape (irregular vs regular)

  • density (homogeneous vs heterogeneous)

  • presence/absence of substantial surrounding oedema that may indicate an underlying tumour

  • presence/absence of intraventricular haemorrhage

  • presence/absence of hydrocephalus

  • when CT angiography is performed, the presence/absence of the CTA spot sign or a vascular malformation

Cases and figures

  • Case 1: ICH (on warfarin)
  • Case 2: basal ganglial bleed
  • Case 3: haemorrhagic infarction
  • Case 4: hypertensive haemorrhage
  • Case 5
  •  Case 6
  • Case 7: coagulopathy
  • Case 8: subacute intracranial haemorrhage
  • Case 9: subacute intracerebral haematoma
  • Case 10
  • Case 11: cerebellar
  • Case 12
  • Case 13: T2*
  • Case 14: hyperacute haemorrhage
  • Case 15: spot sign
  • Case 16: blend sign
  • Case 17: black hole sign
:

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.